These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37957090)

  • 1. Biosafety and biosecurity: treading China's synbio tightrope.
    Lou Y; Tang X; Liao L; Deng Z; Gao J
    Trends Biotechnol; 2024 Apr; 42(4):389-392. PubMed ID: 37957090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and management of the biosecurity for synthetic biology.
    Zeng X; Jiang H; Yang G; Ou Y; Lu S; Jiang J; Lei R; Su L
    Synth Syst Biotechnol; 2022 Jun; 7(2):784-790. PubMed ID: 35387231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's evolving biosafety/biosecurity legislations.
    Cao C
    J Law Biosci; 2021; 8(1):lsab020. PubMed ID: 34221436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building biosecurity for synthetic biology.
    Trump BD; Galaitsi SE; Appleton E; Bleijs DA; Florin MV; Gollihar JD; Hamilton RA; Kuiken T; Lentzos F; Mampuys R; Merad M; Novossiolova T; Oye K; Perkins E; Garcia-Reyero N; Rhodes C; Linkov I
    Mol Syst Biol; 2020 Jul; 16(7):e9723. PubMed ID: 32692486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Better Governance on Biosafety and Biosecurity: China's Advances and Perspectives in Medical Biotechnology Legislation.
    Xue Y; Shang L
    Front Bioeng Biotechnol; 2022; 10():939295. PubMed ID: 35860327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intellectual property and funding: fueling Chinese synbio.
    Liao L; Lou Y; Tang X; Deng Z; Gao J
    Trends Biotechnol; 2024 Mar; 42(3):258-260. PubMed ID: 37980185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state of biosafety across China's CDC microbiology laboratories: insights from a nationwide survey (2021-2023).
    Niu P; Sun Z; Zhang R; Zhao Y; Tian F; Cheng P; Zheng H; Guo J; Zhang M; Ma X; Wang J
    Front Public Health; 2024; 12():1436503. PubMed ID: 39157525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics and engagement: steering China's synbio future.
    Tang X; Liao L; Lou Y; Deng Z; Gao J
    Trends Biotechnol; 2024 May; 42(5):513-516. PubMed ID: 37968158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Brazilian High- and Maximum-Containment Laboratories Biosafety and Biosecurity Regulations to Legal Frameworks in the United States and Other Countries: Gaps and Opportunities.
    Mendonça AO; Zuelke KA; Kahl-Mcdonagh MM; Mafra C
    Appl Biosaf; 2024 Mar; 29(1):45-56. PubMed ID: 38434103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequentialism and the Synthetic Biology Problem.
    Heavey P
    Camb Q Healthc Ethics; 2017 Apr; 26(2):206-229. PubMed ID: 28361719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight Years of Collaboration on Biosafety and Biosecurity Issues Between Kazakhstan and Germany as Part of the German Biosecurity Programme and the G7 Global Partnership Against the Spread of Weapons and Materials of Mass Destruction.
    Peintner L; Wagner E; Shin A; Tukhanova N; Turebekov N; Abdiyeva K; Spaiser O; Serebrennikova Y; Tintrup E; Dmitrovskiy A; Zhalmagambetova A; Frey S; Essbauer SS
    Front Public Health; 2021; 9():649393. PubMed ID: 34434910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Biosecurity in Pakistan: Current Efforts, Challenges, and Recommendations on a Multidimensional Management Strategy.
    Khan T; Tanveer F; Muhammad J
    Health Secur; 2021; 19(3):254-261. PubMed ID: 33956522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR Cautions: Biosecurity Implications of Gene Editing.
    West RM; Gronvall GK
    Perspect Biol Med; 2020; 63(1):73-92. PubMed ID: 32063588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosafety and regulatory issues of RNA therapeutics.
    Thi HV; Thi LN; Tang TL; Chu DT
    Prog Mol Biol Transl Sci; 2024; 204():311-329. PubMed ID: 38458742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
    Orelle A; Nikiema A; Zakaryan A; Albetkova AA; Keita MS; Rayfield MA; Peruski LF; Pierson A
    Health Secur; 2022; 20(6):488-496. PubMed ID: 36383124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Biosafety and Biosecurity in Ukraine.
    Houser RS; Koblentz GD; Lentzos F
    Health Secur; 2023; 21(1):70-80. PubMed ID: 36629857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic bugs on the loose: containment options for deeply engineered (micro)organisms.
    Schmidt M; de Lorenzo V
    Curr Opin Biotechnol; 2016 Apr; 38():90-6. PubMed ID: 26874261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SynBio Africa's story from the grassroots, the present, and the future.
    Otim G; Matinyi S; Baluku E; Chimulwa ISG; Magoola GP; Katumba A; Mukuze S; Kyabarongo A; Opiyo SO
    Biotechnol Notes; 2023; 4():1-6. PubMed ID: 39416917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sustainable balance between innovation and risk: How the "right to science" affects China's medical biotechnology regulatory policy.
    Han Y; Fan LL; Xue Y
    Comput Struct Biotechnol J; 2024 Dec; 24():306-313. PubMed ID: 38681134
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.